Results 1 to 10 of about 111,329,672 (189)

Yin Yang 1 (YY1) as a Central Node in Drug Resistance Pathways: Potential for Combination Strategies in Cancer Therapy [PDF]

open access: yesBiomolecules
Tumor drug resistance, a major cause of treatment failure, involves complex multi-gene networks, remodeling of signaling pathways, and interactions with the tumor microenvironment.
Zhiyan Li   +4 more
doaj   +7 more sources

The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1 [PDF]

open access: yesFrontiers in Cell and Developmental Biology, 2020
First described in 1991, Yin Yang 1 (YY1) is a transcription factor that is ubiquitously expressed throughout mammalian cells. It regulates both transcriptional activation and repression, in a seemingly context-dependent manner.
Thijs C. J. Verheul   +3 more
doaj   +8 more sources

Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery [PDF]

open access: yesBMC Gastroenterology, 2018
Background This study is to investigate the association between the hepatic expression of Yin Yang 1 (YY1) and the progression of non-alcoholic fatty liver disease (NAFLD) in patients undergoing bariatric surgery.
Xianwen Yuan   +10 more
doaj   +4 more sources

Induction of Yin Yang 1 (YY1) Overexpression in Mature Adipocytes Promotes Dysfunctional Adipose Tissue and Systemic Insulin Resistance in Mice [PDF]

open access: yesMetabolism: Clinical and Experimental
The ubiquitous transcription factor Ying Yang 1 (YY1) plays a fundamental role in multiple biological processes and is believed to regulate up to 10 % of all human genes. In thermogenic brown adipose tissue, YY1 has been linked to controlling mitochondrial gene expression and regulating cellular oxidative respiration, protecting against diet-induced ...
Pedersen L   +10 more
exaly   +5 more sources

CRTAC1 (Cartilage Acidic Protein 1) Inhibits Cell Proliferation, Migration, Invasion and Epithelial-Mesenchymal Transition (EMT) Process in Bladder Cancer by Downregulating Yin Yang 1 (YY1) to Inactivate the TGF-β Pathway [PDF]

open access: yesBioengineered, 2021
Cartilage acidic protein 1 (CRTAC1) is predicted to be aberrantly expressed in bladder cancer based on bioinformatics analysis. However, its functions and molecular mechanism in bladder cancer remain elusive. This study aimed to explore the role of CRTAC1 in bladder cancer.
Hailong Hu, Xiaoxing Liao
exaly   +5 more sources

Yin Yang 1 Promotes Antiprogrammed Cell Death‐1 Resistance in Hepatocellular Carcinoma through Polypeptide N‐Acetylgalactosaminyltransferase 16‐Mediated Glycosylation of Programmed Death Ligand‐1 [PDF]

open access: yesMedComm
Immune checkpoint inhibitors (ICIs) are widely used for treating hepatocellular carcinoma (HCC), yet their efficacy remains limited, with suboptimal response rates.
Shu‐sheng Lin   +11 more
doaj   +2 more sources

Unraveling the RKIP–YY1 axis: immune crosstalk in the pathogenesis of metabolic disorders [PDF]

open access: yesFrontiers in Immunology
Metabolic diseases, including obesity, type 2 diabetes, and cardiovascular disorders, are increasingly recognized as chronic inflammatory conditions driven by dysregulated immune-metabolic interactions.
Fawaz Alzaid   +10 more
doaj   +2 more sources

HDAC1/3-dependent moderate liquid–liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation

open access: yesCell Death and Disease, 2022
Methyltransferase-like protein 3 (METTL3) plays critical roles in acute myeloid leukemia (AML) progression, however, the mechanism of abnormal overexpression of METTL3 in AML remain elusive.
Meng Li   +9 more
doaj   +1 more source

Dissecting the roles and clinical potential of YY1 in the tumor microenvironment

open access: yesFrontiers in Oncology, 2023
Yin-Yang 1 (YY1) is a member of the GLI-Kruppel family of zinc finger proteins and plays a vital dual biological role in cancer as an oncogene or a tumor suppressor during tumorigenesis and tumor progression.
MengNa Li   +33 more
doaj   +1 more source

Home - About - Disclaimer - Privacy